Meta-Analysis of Transcatheter Aortic Valve Implantation in Patients With Stenotic Bicuspid Versus Tricuspid Aortic Valve.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
15 04 2021
Historique:
received: 03 10 2020
revised: 28 12 2020
accepted: 31 12 2020
pubmed: 19 1 2021
medline: 17 4 2021
entrez: 18 1 2021
Statut: ppublish

Résumé

Most of the trials investigating the role of transcatheter aortic valve implantation (TAVI) across various strata of risk categories have excluded patients with bicuspid aortic stenosis (BAS) due to its anatomical complexities. The aim of this study was to perform a meta-analysis with meta-regression of studies comparing clinical, procedural, and after-procedural echocardiographic outcomes in BAS versus tricuspid aortic stenosis (TAS) patients who underwent TAVI. We searched the PubMed and Cochrane databases for relevant articles from the inception of the database to October 2019. Continuous and categorical variables were pooled using inverse variance and Mantel-Haenszel method, respectively, using the random-effect model. To rate the certainty of evidence for each outcome, we used the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) approach. Nineteen articles were included in the final analysis. There was no difference in the risk of 30-day mortality, 1-year mortality, 30-day cardiovascular mortality, major and/or life-threatening bleeding, major vascular complications, acute kidney injury, permanent pacemaker implantation, device success, annular rupture, after-procedural aortic valve area, and mean pressure gradient between the 2 groups. BAS patients who underwent TAVI had a higher risk of 30-day stroke, conversion to surgery, need for second valve implantation, and moderate to severe paravalvular leak. In conclusion, the present meta-analysis supports the feasibility of TAVI in surgically ineligible patients with BAS. However, the incidence of certain procedural complications such as stroke, conversion to surgery, second valve implantation, and paravalvular leak is higher among BAS patients compared with TAS patients, which must be discussed with the patient during the decision-making process.

Identifiants

pubmed: 33460604
pii: S0002-9149(21)00043-6
doi: 10.1016/j.amjcard.2020.12.085
pii:
doi:

Types de publication

Comparative Study Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-110

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures The authors declare no conflicts of interest. Note: All authors had access to the data and a role in writing the manuscript. The present work was conducted at New York Medical College, Metropolitan Hospital Centre.

Auteurs

Monil Majmundar (M)

Department of Internal Medicine, Metropolitan Hospital Center, New York Medical College, New York, New York.

Ashish Kumar (A)

Department of Critical Care Medicine, St John's Medical College Hospital, Bangalore, India.

Rajkumar Doshi (R)

Department of Internal Medicine, University of Nevada Reno School of Medicine, Reno, Nevada. Electronic address: raj20490@gmail.com.

Palak Shah (P)

Department of Internal Medicine, Dhiraj Hospital, Sumandeep Vidyapeeth, Vadodara, Gujarat, India.

Shilpkumar Arora (S)

Department of Cardiology, Case Western Reserve University, Cleveland, Ohio.

Mariam Shariff (M)

Department of Critical Care Medicine, St John's Medical College Hospital, Bangalore, India.

Devina Adalja (D)

Department of Medicine, GMERS Gotri Medical College, Vadodara, Gujarat, India.

Ferdinand Visco (F)

Division of Cardiology, Department of Internal Medicine, Metropolitan Hospital Center, New York Medical College, New York, New York.

Hossam Amin (H)

Division of Pulmonary and Critical Care, Metropolitan Hospital Center, New York Medical College, New York, New York.

Saraschandra Vallabhajosyula (S)

Section of Intervention Cardiology, Division of Cardiovascular Medicine, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.

Nageshwara Gullapalli (N)

Department of Internal Medicine, University of Nevada Reno School of Medicine, Reno, Nevada.

Samir R Kapadia (SR)

Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio.

Ankur Kalra (A)

Department of Cardiovascular Medicine, Heart, Vascular, and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio; Section of Cardiovascular Research, Heart, Vascular, and Thoracic Department, Cleveland Clinic Akron General, Akron, Ohio.

Sidakpal S Panaich (SS)

Department of Cardiovascular Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH